JD Lundgren

Safety of non-nucleoside reverse transcriptase therapy: data from the EuroSIDA study

Andrew N. Phillips, Nina Friis-Møller, Ole Kirk, 2003 .

Loss to follow‐up in an international, multicentre observational study

JD Lundgren, A Mocroft, O Kirk, 2008, HIV medicine.

Changing patterns of mortality across Europe in patients infected with HIV-1

JD Lundgren, A Mocroft, A. Mocroft, 1998, The Lancet.

Updated European Recommendations for the Clinical Use of HIV Drug Resistance Testing

JD Lundgren, N Clumeck, A. D. Luca, 2004, Antiviral therapy.

Prediction of phenotypic susceptibility to antiretroviral drugs using physiochemical properties of the primary enzymatic structure combined with artificial neural networks

JD Lundgren, Z. Fox, J. Lundgren, 2008, HIV medicine.

Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study

JD Lundgren, N Clumeck, A. Mocroft, 2007, The Lancet.